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Chronic diseases (cardiovascular, cancer and others) cause the life quality deterioration and early
aging. The development of early preclinical human pathology detection methods is necessary for
implementation of the modern “4Pmedicine” paradigm—Predictive, Personalized, Preventive, and
Participatory.
A non-invasivemultiorgan karyological test for early diagnostics of health state was developed in
a laboratory of genetic monitoring of the Research Institute of Human Ecology and Environmental
Health named after A. N. Sysin (Moscow). The method involves microscopic studies of buccal,
nasal, urothelial and/or bronchial epithelial cells which includes the entire spectrum of cells
nuclei states morphological evaluation. In 1992, Tolbert et al. proposed a method of evaluation of
nuclear abnormalities in the human buccal cells. The International Project Human Micronucleus
Assay in exfoliated cells (HUMNxl) was initiated in 2007 (www.humn.org; Bolognesi et al., 2013).
We proposed to increase the number of investigated biomarkers, tissues and integral indicators.
We have also determined the indicative guideline values. We propose to consider the following
biomarkers: cytogenetic biomarkers (number of micronuclei, nuclear buds and additionally—
atypical nuclei); biomarkers of proliferation (binucleated cells and cells with double nuclei) and
biomarkers of cell death, which include cells with early destruction of nucleus (with perinuclear
vacuoles, nucleus membrane damage, chromatin condensation and vacuolization, early karyolysis)
as well as cells with late destruction of nucleus (pycnosis, karyorrhexis, and late karyolysis). The
determination and categorization criteria for diagnostic signs of the entire spectrum of karyological
biomarkers was described earlier (Sycheva, 2007). Considering the karyological biomarkers
categorization, including of cytogenetic parameters (cyt), proliferation (pr) and destruction of
nucleus (apop), an accumulative cytogenetic damage index formula [Iac = (Icyt × Ipr/Iapop) ×
100] as well as three levels of cytogenetic stress (low, acceptable, or high) were proposed (Sycheva,
2012).
Exfoliative cells are renewed during 10–14 days, so cytogenetic status can be monitored and
corrected. It is recommended carrying out analysis of cytogenetic status 2 times in year. If the level
of cytogenetic stress is high, it is necessary to determine factors inducing the DNA damage by
means of interviewing a patient (eating habits, medication, working conditions, living conditions,
social habits, solarium usage, etc.). Taking into account the predominating free radical mechanism
of cell damage the vitamin-mineral antioxidant complexes administering may be proposed by
recommended daily intakes to eliminate or minimize the identified risk factors. The next evaluation
of patient’s cytogenetic status is necessary to carry out after 2–3 months to determine the direction
of changes. We used this approach to evaluate the influence on the population genetic state of
Sycheva Diagnostics, correction and prophylaxis of prepathological states
such environmental factors as dioxins, oil-contaminated
soils, complex pollution of pulp and paper mill, metallurgical
plants, coffee-production enterprise the large office in Moscow
etc. Our studies revealed significantly higher numbers of
exfoliated cells with cytogenetic damage and, in some cases,
the level of apoptosis decreased in the group exposed to
environmental pollution, compared to the control group.
Decreased apoptosis is very adverse for the population, as
it may lead to the accumulation of cytogenetically damaged
cells as well as to the cancer induction. Positive results and
improvement of human cytogenetic status were obtained after
administering of antioxidants. In our study 52% of students have
demonstrated decrease frequency of cytogenetically damaged
cells after the 1 month of vitamins A and C administration,
38% of students did not have changes, 10% of students have
demonstrated higher level of damaged cells within the indicative
guideline values range. On the whole the frequency of cells
with cytogenetic damage was decreased from 1.93 to 1.17h
(P < 0.05) and apoptotic index was increased from 30.3 to 36.7h
(P < 0.001) (Abasova et al., 2012). Approximately the same
results were obtained after the vitamin and mineral complexes
≪ Helvesana ≫, ≪ Lenedex ≫, ≪ Celergen ≫ administering
in studies carried out in collaboration with professor
Trukhanov et al.
This approach enables the development of “Medicine 4P”
paradigm. The “Predictive” medicine concept is based on the
analysis of the objective biomarkers of human cytogenetic
status and the analysis of epithelial cells which are the
most exposed to neoplastic transformation. The “Personalized”
medicine means that the evaluation of the cytogenetic status
can be carried out for each person and the cytogenetic status
monitoring allows determination of deleterious conditions. The
“Preventive” medicine concept suggests determination of the
earliest deleterious effects before their clinical manifestations.
The “Participatory” medicine expects patient participation using
non-invasive methods for monitoring their own cytogenetic
status at the preclinical stages. The elimination and correction
of genotoxic environmental factors may be attempted in
cooperation with a patient in order to control and improve their
personal cytogenetic status.
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